Andreas SCHROEDER,Christoph HELWIG,Anja-Helena LOOS,Armin SCHUELER,Martin FALK,Charles BUTTS,Frances A. SHEPHERD
申请号：
US14891557
公开号：
US20160067322A1
申请日:
2014.04.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention is directed to the treatment of lung cancer, preferably non-small cell lung cancer (NSCLC) by means of a combination therapy comprising concurrent chemo-radiotherapy followed by vaccination with a muc-1 lipopetide. The therapy elicits prolonged survival rates compared to a respective therapy including sequential chemo-radiotherapy.
